Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease

(2013) Han-Yun Hsiao et al.   HUMAN MOLECULAR GENETICS

Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression

(2012) Andreas Weiss et al.   JOURNAL OF CLINICAL INVESTIGATION

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease

(2012) Valerio Pisani et al.   Journal of Neuroinflammation

Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease

(2012) W. Kwan et al.   JOURNAL OF NEUROSCIENCE

Regulation of Feedback between Protein Kinase A and the Proteasome System Worsens Huntington's Disease

(2012) J.-T. Lin et al.   MOLECULAR AND CELLULAR BIOLOGY

Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination

(2011) Roberta Brambilla et al.   BRAIN

Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB

(2011) Era Taoufik et al.   BRAIN

Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective

(2011) AK Ho et al.   CLINICAL GENETICS

Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification

(2011) Hsiang-Po Huang et al.   HUMAN MOLECULAR GENETICS

Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

(2011) Tz-Chuen Ju et al.   JOURNAL OF CELL BIOLOGY

Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats

(2011) Harikesh Kalonia et al.   LIFE SCIENCES

Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction

(2011) Albert Giralt et al.   Molecular Neurodegeneration

The role of IκB kinase complex in the neurobiology of Huntington's disease

(2011) Ali Khoshnan et al.   NEUROBIOLOGY OF DISEASE

Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro

(2010) Ayako Furuya et al.   Journal of Inflammation-London

Effects of muscle fatigue on gait characteristics under single and dual-task conditions in young and older adults

(2010) Urs Granacher et al.   Journal of NeuroEngineering and Rehabilitation

Tumor necrosis factor blockade and the risk of viral infection

(2010) Seo Young Kim et al.   Nature Reviews Rheumatology

Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-ϒ (PPARϒ) in Huntington's disease

(2010) Harikesh Kalonia et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Infectious complications of tumor necrosis factor blockade

(2009) Robert S Wallis   CURRENT OPINION IN INFECTIOUS DISEASES

Immunological synapse formation inhibits, via NF-κB and FOXO1, the apoptosis of dendritic cells

(2009) Lorena Riol-Blanco et al.   NATURE IMMUNOLOGY

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

(2009) Fiona E. McAlpine et al.   NEUROBIOLOGY OF DISEASE

Inflammatory demyelinating events following treatment with anti-tumor necrosis factor

(2008) A. Fromont et al.   CYTOKINE

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

(2008) Maria Björkqvist et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes

(2008) S.-Y. Chou et al.   JOURNAL OF NEUROSCIENCE